MetaVia Inc. — Director's Dealing 2017

Mar 29, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2017-03-28

Reporting Person: Golden Lee Scott (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-28	Employee Stock Option (right to buy)	$11.15	A	20000	Acquired	2027-03-27	Common Stock (20000)	Direct

Footnotes

F1: The option vests in a series of forty-eight successive equal monthly installments on the last day of each month, commencing on the grant date.